July 15, 2025

Applying Patient Behavioral Assessment to Enhance Dental Implant Treatment Outcomes

Despite its critical role, behavioral assessment remains underutilized due to a lack of standardized tools.

Compendium

July 09, 2025

Zanidatamab Plus Chemotherapy in Advanced HER2-Positive Gastroesophageal Adenocarcinoma

In a phase II trial reported in The Lancet Oncology, Elimova et al evaluated the efficacy and safety of zanidatamab plus chemotherapy in the first-line treatment of patients with advanced HER2-positiv...

The ASCO Post

June 27, 2025

Weight Loss Drugs, Heavier Implications

New guidance positions GLP-1 and GLP-1/GIP therapies as frontline options for long-term weight management—with profound implications for cardiovascular outcomes, access equity, and chronic disease care.

Conexiant

June 12, 2024

USPSTF Releases Draft Osteoporosis Screening Guidelines

The USPSTF's draft recommendations reaffirm osteoporosis screening for older women, call for more research on screening men, and address health disparities.

Conexiant

July 29, 2024

Management of Elevated BP in Hospitalized Patients: A New Approach

A recent clinical insights article presents a new framework for managing asymptomatic elevated blood pressure in hospitalized patients, challenging current practices by emphasizing a cautious approach based on recent observational studies.

Conexiant

February 13, 2024

With Empathy and Advanced Care, Mount Sinai-Rainbow Clinic Supports Full-Term Births After Perinatal Loss

The Mount Sinai-Rainbow Clinic is the first of its kind in the United States. Its multidisciplinary team members have special training to understand and respond to the special circumstances and sensitivities of parents who have experienced perinatal loss.

Mount Sinai New York

November 14, 2023

Novel Immunotherapy Approach at Roswell Park Shows Promise in Metastatic Triple-Negative Breast Cancer

Short-term regimen effectively ‘reprograms’ tumor prior to additional immunotherapy

Roswell Park Comprehensive Cancer Center

January 12, 2023

What to Know About the Recently Approved Alzheimer’s Drug

Leqembi, Newly Approved by FDA, Shows Potential Benefit for Patients With Early-Stage Disease, But Availability Will Take Time, Says Cedars-Sinai Expert

Cedars-Sinai Pulse

March 07, 2025

New Clinical Guideline for Benzodiazepine Tapering Released

The new clinical practice guideline, developed in tandem by representatives from 10 medical societies, provides evidence-based and consensus recommendations for safe benzodiazepine tapering when risks outweigh benefits.

Conexiant